Post-Traumatic Stress Disorder Pipeline Market Reviews in H1 2017 for PTSD Drug Development and Therapeutics Assessment The Post-Traumatic Stress Disorder (PTSD) condition may last months or years, with triggers that can bring back memories of the trauma accompanied by intense emotional and physical reactions. PTSD Post-Traumatic Stress Disorder Pipeline Market Report provides the latest projects and drug profiles with key companies. Post-traumatic stress disorder (PTSD) is a mental health condition that's triggered by a terrifying event either experiencing it or witnessing it. Symptoms include flashbacks, nightmares and severe anxiety, as well as uncontrollable thoughts about the event. Treatment includes antidepressants, anti-anxiety and cognitive therapy. Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=911447 . Pharmaceutical and Healthcare latest pipeline guide Post-Traumatic Stress Disorder (PTSD) Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Post-Traumatic Stress Disorder (PTSD) (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Key Company Profiles are Addex Therapeutics Ltd, Amorsa Therapeutics Inc, Azevan Pharmaceuticals Inc, Bionomics Ltd, Catalyst Pharmaceuticals Inc, Cerecor Inc, Chronos Therapeutics Ltd, Corcept Therapeutics Inc, Eli Lilly and Company, Embera NeuroTherapeutics Inc, Intra-Cellular Therapies Inc, INVENT Pharmaceuticals Inc, Marinus Pharmaceuticals Inc, Neuralstem Inc, NeuroNascent Inc, Omeros Corp, Otsuka Holdings Co Ltd, Pragma Therapeutics SAS, Synchroneuron Inc, Tonix Pharmaceuticals Holding Corp, TRImaran Pharma Inc. Post-Traumatic Stress Disorder (PTSD) - Drug Profiles (metyrapone + oxazepam) - Drug Profile, acamprosate calcium SR - Drug Profile, ADX-71743 Drug Profile, AM-3506 - Drug Profile, BNC-210 - Drug Profile, brexpiprazole - Drug Profile, CERC501 - Drug Profile, CPP-115 - Drug Profile, CTDP-003 - Drug Profile, D-473 - Drug Profile, ganaxolone - Drug Profile, IC-87201 - Drug Profile, INV-107 - Drug Profile, KDAC-0001 - Drug Profile, lumateperone tosylate - Drug Profile, midomafetamine - Drug Profile, modafinil - Drug Profile, NNI-351 - Drug Profile, NSI-189 - Drug Profile, PGT-117 - Drug Profile, Rycal - Drug Profile, Synthetic Peptide to Antagonize EPHA4 for Post-Traumatic Stress Disorder - Drug Profile, Synthetic Peptide to Target NPSR for Anxiety Disorder - Drug Profile, tianeptine - Drug Profile, TNX-102 - Drug Profile, Vaccine for CNS Disorders - Drug Profile, ZL-006 - Drug Profile.
www.reportsnreports.com
Post-Traumatic Stress Disorder Pipeline Market Reviews in H1 2017 for PTSD Drug Development and Therapeutics Assessment Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=911447 Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Scope The pipeline guide provides a snapshot of the global therapeutic landscape of Post-Traumatic Stress Disorder (PTSD) (Central Nervous System). The pipeline guide reviews pipeline therapeutics for Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. The pipeline guide reviews key companies involved in Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=911447 .
www.reportsnreports.com
Post-Traumatic Stress Disorder Pipeline Market Reviews in H1 2017 for PTSD Drug Development and Therapeutics Assessment Table of Contents: Post-Traumatic Stress Disorder - Overview Post-Traumatic Stress Disorder - Therapeutics Development Post-Traumatic Stress Disorder Pipeline Overview Post-Traumatic Stress Disorder Pipeline by Companies Post-Traumatic Stress Disorder Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes Post-Traumatic Stress Disorder - Therapeutics Assessment Post-Traumatic Stress Disorder - Companies Involved in Therapeutics Development Post-Traumatic Stress Disorder - Drug Profiles Post-Traumatic Stress Disorder - Dormant Projects Post-Traumatic Stress Disorder - Product Development Milestones List of Tables. Number of Products under Development for Post-Traumatic Stress Disorder (PTSD), H1 2017 Number of Products under Development by Companies, H1 2017 Number of Products by Stage and Target, H1 2017 Number of Products by Stage and Route of Administration, H1 2017 Number of Products by Stage and Molecule Type, H1 2017 Post-Traumatic Stress Disorder (PTSD) - Pipeline by Addex Therapeutics Ltd, H1 2017 Post-Traumatic Stress Disorder (PTSD) - Pipeline by Amorsa Therapeutics Inc, H1 2017 Post-Traumatic Stress Disorder (PTSD) - Pipeline by Azevan Pharmaceuticals Inc, H1 2017 Post-Traumatic Stress Disorder (PTSD) - Pipeline by Bionomics Ltd, H1 2017 Post-Traumatic Stress Disorder (PTSD) - Pipeline by TRImaran Pharma Inc, H1 2017 Post-Traumatic Stress Disorder (PTSD) - Dormant Projects, H1 2017 Post-Traumatic Stress Disorder (PTSD) - Discontinued Products, H1 2017 About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with your contact details.
www.reportsnreports.com